Azacitidine Maintenance Therapy After Allogeneic Bone Marrow Transplantation (Allo BMT)

NCT00350818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Leukemia

Interventions

DRUG: Azacitidine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]